References
- Schurgers E, Kelchtermans H, Mitera T, et al. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther 2010;12:1–11
- Gong FY, Shen Y, Zhang Q, et al. Obaculactone suppresses Th1 effector cell function through down-regulation of T-bet and prolongs skin graft survival in mice. Biochem Pharmacol 2010;15:218–225
- Huang YW, Wang LS, Chang HL, et al. Molecular mechanisms of (−)-gossypol-induced apoptosis in human prostate cancer cells. Anticancer Res 2006;26:1925–1934
- Yu ZH, Chan HC. Gossypol as a male antifertility agent – why studies should have been continued. Int J Androl 1998;21:2–7
- Choi YH, Jin GY, Li GZ, et al. Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW 264.7 macrophages. Biol Pharm Bull 2011;34:959–966
- Zhu Y, Xie SW, Zhang JF, et al. Involvement of Bcl-2, Src, and ERα in gossypol-mediated growth inhibition and apoptosis in human uterine leiomyoma and myometrial cells. Acta Pharmacol Sin 2010;31:1593–1603
- Mehmet AE, Ece K, Deniz E, et al. Apoptosis and nitric oxide release induced by thalidomide, gossypol and dexamethasone in cultured human chronic myelogenous leukemic K-562 cells. Cell Biol Int 2004;28:237–242
- Achudume AC, Adepoju AY, Adu KA, et al. Experimental analysis of gossypol and chloroquine interaction in serum and in liver of rat. Indian J Exp Biol 1998;36:1020–1022
- Tai-Shun L, Raymond S, Brigitte PG, et al. Selective inhibition of human immunodeficiency virus type 1 replication by the (−) but not the (+) enantiomer of gossypol. Antimicrob Agents Ch 1989;33:2149–2151
- Kalliopi D, Rosaleen JA, John L, et al. Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity. Bioorgan Med Chem 2005;13:4228–4237
- Xu PP, Ye WP, Lin SH, et al. Mitogenic activity of zeranol in human breast cancer cells is enhanced by leptin and suppressed by gossypol. Anticancer Res 2009;29:4621–4628
- Jiang JH, Sugimoto Y, Liu SL, et al. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFβ1) signal transduction pathway. Anticancer Res 2004;24:91–100
- Xu WB, Xu LH, Lu HS, et al. The immunosuppressive effect of gossypol in mice is mediated by inhibition of lymphocyte proliferation and by induction of cell apoptosis. Acta Pharmacol Sin 2009;30:597–604
- Zuckermann FA. Extrathymic CD4/CD8 double positive T cells. Vet Immunol Immunop 1999;72:55–56
- Shan X, Chen L, Cao M, et al. Effects of human soluble BAFF synthesized in Escherichia coli on CD4+ and CD8+ T lymphocytes as well as NK cells in mice. Physiol Res Praha 2006;55:301–305
- Taleb S, Tedgui A, Mallat Z. Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol 2010;10:197–202
- Jackson LJ, Pheneger JA, Pheneger TJ, et al. The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease. Cell Immunol 2012;272:200–213
- Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007;282:9358–9363
- Wen ZS, Xu YL, Zou XT, et al. Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Mar Drugs 2011;9:1038–1055
- Checker R, Sandur SK, Sharma D. Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-κB, AP-1 and NF-AT. PLoS One 2012;7:e31318
- Fiebich BL, Collado JA, Stratz C, et al. Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways. Immunopharmacol Immunotoxicol 2012;34:98–106